WallStreetZenWallStreetZen

NASDAQ: ACHV
Achieve Life Sciences Inc Stock Ownership - Who owns Achieve Life Sciences?

Insider buying vs selling

Have Achieve Life Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jerry WanPrincipal Accounting Officer2024-04-192,250$4.51
$10.15kSell
John BencichCEO2024-04-196,088$4.51
$27.46kSell
Cindy JacobsPresident CMO2024-04-193,957$4.51
$17.85kSell
Richard Alistair StewartExecutive Chairman2024-04-1910,125$4.51
$45.66kSell
Richard Alistair StewartExecutive Chairman2024-03-0410,000$4.59
$45.85kBuy
John BencichCEO2024-03-0410,000$4.59
$45.85kBuy
John BencichCEO2023-05-305,000$5.50
$27.50kBuy
Richard Alistair StewartExecutive Chairman2023-04-282,250$8.29
$18.65kSell
Cindy JacobsPresident CMO2023-04-28609$8.29
$5.05kSell
John BencichCEO2023-04-281,827$8.29
$15.15kSell

1 of 2

ACHV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACHV insiders and whales buy or sell their stock.

ACHV Shareholders

What type of owners hold Achieve Life Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Dialectic Capital Management LP10.36%3,549,000$15.97MInsider
Robert Schacter5.34%1,827,426$8.22MInsider
Armistice Capital LLC4.65%1,593,188$7.17MInsider
Ventures West Capital Ltd2.83%968,582$4.36MInsider
Shay Capital LLC2.12%725,000$3.26MInstitution
Vanguard Group Inc1.77%605,710$2.73MInstitution
Hig Oncogenex Inc1.59%545,512$2.45MInsider
Anthony Clarke1.59%545,138$2.45MInsider
Long Focus Capital Management LLC0.72%248,099$1.12MInstitution
Geode Capital Management LLC0.54%184,925$832.16kInstitution

1 of 3

ACHV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACHV7.96%27.78%Net SellingNet Selling
AGEN63.15%36.85%Net BuyingNet Buying
ACET40.62%19.50%Net Buying
CAPR11.24%88.76%Net BuyingNet Buying
CRVO0.47%99.53%

Achieve Life Sciences Stock Ownership FAQ

Who owns Achieve Life Sciences?

Achieve Life Sciences (NASDAQ: ACHV) is owned by 7.96% institutional shareholders, 27.78% Achieve Life Sciences insiders, and 64.26% retail investors. Dialectic Capital Management LP is the largest individual Achieve Life Sciences shareholder, owning 3.55M shares representing 10.36% of the company. Dialectic Capital Management LP's Achieve Life Sciences shares are currently valued at $16.11M.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.